Cara Tomas: Difference between revisions

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
VisualWikitext
m (Text replacement - "Mitochondria" to "Mitochondrion")
m (Text replacement - "u| first" to "u | first")
 
(139 intermediate revisions by 2 users not shown)
Line 1: Line 1:
[[File:Cara Tomas.png|200px|thumb|right]]
[[File:Cara Tomas.png|200px|thumb|right]]
'''Cara Tomas''', PhD, is a Postdoctoral Research Associate at the [http://www.ncl.ac.uk/icm/research/ Institute of Cellular Medicine], Newcastle University, Newcastle upon Tyne, [[United Kingdom|UK]]. Tomas' interest in [[ME/CFS]] stems from her own experience with acute onset ME/CFS leaving her bedbound for a time.<ref name=":0">{{Cite journal|last=Streeten|first=David H. P.|last2=BellMD|first2=David S.|date=Jan 1998|title=Circulating Blood Volume in Chronic Fatigue Syndrome|url=http://dx.doi.org/10.1300/j092v04n01_02|journal=Journal of Chronic Fatigue Syndrome|volume=4|issue=1|pages=3–11|doi=10.1300/j092v04n01_02|issn=1057-3321}}</ref>
'''Cara Tomas''', PhD, is a Postdoctoral Research Associate at the [http://www.ncl.ac.uk/icm/research/ Institute of Cellular Medicine], Newcastle University, Newcastle upon Tyne, [[United Kingdom|UK]]. Tomas' interest in [[ME/CFS]] stems from her own experience with acute onset ME/CFS leaving her bedbound for a time.<ref name=":0">{{Cite journal | last = Streeten | first = David H.P. | last2 = Bell | first2 = David S. | date = Jan 1998 | title = Circulating Blood Volume in Chronic Fatigue Syndrome | url =http://dx.doi.org/10.1300/j092v04n01_02 | journal = Journal of Chronic Fatigue Syndrome | volume = 4 | issue = 1 | pages = 3–11|doi=10.1300/j092v04n01_02|issn=1057-3321}}</ref>


==Notable studies==
==Notable studies==
*2017, Cellular [[bioenergetics]] is impaired in patients with chronic fatigue syndrome<ref>{{Cite journal|last=Tomas|first=Cara|author-link=Cara Tomas|last2=Brown|first2=Audrey|author-link2=Audrey Brown|last3=Strassheim|first3=Victoria|author-link3=Victoria Strassheim|last4=Elson|first4=Joanna|last5=Newton|first5=Julia|author-link5=Julia Newton|last6=Manning|first6=Philip|date=Oct 24, 2017|title=Cellular bioenergetics is impaired in patients with chronic fatigue syndrome|url=http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0186802|journal=PLOS ONE|language=en|volume=12|issue=10|pages=e0186802|doi=10.1371/journal.pone.0186802|issn=1932-6203|pmc=|pmid=29065167|via=}}</ref> - [http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0186802 (Full Text)]
*2017, Cellular [[bioenergetics]] is impaired in patients with chronic fatigue syndrome<ref>{{Cite journal | last = Tomas | first = Cara | author-link = Cara Tomas | last2 = Brown | first2 = Audrey | author-link2 = Audrey Brown | last3 = Strassheim | first3 = Victoria | author-link3 = Victoria Strassheim | last4 = Elson | first4 = Joanna | last5 = Newton | first5 = Julia | author-link5 = Julia Newton | last6 = Manning | first6 = Philip | date = Oct 24, 2017 | title = Cellular bioenergetics is impaired in patients with chronic fatigue syndrome | url =http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0186802 | journal = PLOS ONE|language=en | volume = 12 | issue = 10| pages = e0186802|doi=10.1371/journal.pone.0186802|issn=1932-6203|pmc=|pmid=29065167|via=}}</ref> - [http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0186802 (Full Text)]
*2017, Elevated brain natriuretic peptide levels in chronic fatigue syndrome associate with [[Cardiac problems in ME/CFS|cardiac dysfunction]]: a case control study<ref name="Tomas, 2017" /> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5761285/ (Full Text)]
*2017, Elevated brain natriuretic peptide levels in chronic fatigue syndrome associate with [[Cardiac problems in ME/CFS|cardiac dysfunction]]: a case control study<ref name="Tomas, 2017" /> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5761285/ (Full Text)]
*2018, [[Metabolic]] abnormalities in chronic fatigue syndrome/myalgic encephalomyelitis: a mini-review<ref name="Tomas, 2018" /> - [https://www.ncbi.nlm.nih.gov/pubmed/29666214 (Abstract)]
*2018, [[Metabolic]] abnormalities in chronic fatigue syndrome/myalgic encephalomyelitis: a mini-review<ref name="Tomas, 2018" /> - [https://www.ncbi.nlm.nih.gov/pubmed/29666214 (Abstract)]
* 2018, A new approach to find [[Diagnostic biomarker|biomarkers]] in [[ME/CFS|chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME)]] by single-cell Raman micro-spectroscopy<ref>{{Cite journal|last=Xu|first=Jiabao|last2=Potter|first2=Michelle|last3=Tomas|first3=Cara|author-link3=Cara Tomas|last4=Elson|first4=Jo|last5=Morten|first5=Karl|author-link5=Karl Morten|last6=Poulton|first6=Joanna|last7=Wang|first7=Ning|last8=Jin|first8=Hanqing|last9=Hou|first9=Zhaoxu|date=2018|title=A new approach to find biomarkers in chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) by single-cell Raman micro-spectroscopy|url=https://pubs.rsc.org/en/content/articlelanding/2018/an/c8an01437j/unauth#!divRelatedContent&articles|journal=The Analyst|language=en|volume=|pages=|doi=10.1039/C8AN01437J|issn=0003-2654|via=}}</ref> - [https://pubs.rsc.org/en/content/articlelanding/2018/an/c8an01437j/unauth#!divRelatedContent&articles (Abstract)]
* 2018, A new approach to find [[Diagnostic biomarker|biomarkers]] in [[ME/CFS|chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME)]] by single-cell Raman micro-spectroscopy<ref>{{Cite journal | last = Xu | first = Jiabao | last2 = Potter | first2 = Michelle | last3 = Tomas | first3 = Cara | author-link3 = Cara Tomas | last4 = Elson | first4 = Jo | last5 = Morten | first5 = Karl | author-link5 = Karl Morten | last6 = Poulton | first6 = Joanna | last7 = Wang | first7 = Ning | last8 = Jin | first8 = Hanqing | last9 = Hou | first9 = Zhaoxu | date = 2018 | title = A new approach to find biomarkers in chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) by single-cell Raman micro-spectroscopy | url = https://pubs.rsc.org/en/content/articlelanding/2018/an/c8an01437j/unauth#!divRelatedContent&articles | journal = The Analyst|language=en | volume = | pages=|doi=10.1039/C8AN01437J|issn=0003-2654|via=}}</ref> - [https://pubs.rsc.org/en/content/articlelanding/2018/an/c8an01437j/unauth#!divRelatedContent&articles (Abstract)]
*2019, [[Mitochondrial DNA|MtDNA]] population variation in Myalgic encephalomyelitis/Chronic fatigue syndrome in two populations: A study of mildly deleterious variants<ref>{{Cite journal|last=Venter|first=Marianne|author-link=|last2=Tomas|first2=Cara|author-link2=Cara Tomas|last3=Pienaar|first3=Ilse S.|author-link3=|last4=Strassheim|first4=Victoria|author-link4=Victoria Strassheim|last5=Erasmus|first5=Elardus|author-link5=|last6=Ng|first6=Wan-Fai|author-link6=|last7=Howell|first7=Neil|last8=Newton|first8=Julia L.|author-link8=Julia Newton|last9=Van der Westhuizen|first9=Francois H.|date=Dec 2019|title=MtDNA population variation in Myalgic encephalomyelitis/Chronic fatigue syndrome in two populations: a study of mildly deleterious variants|url=http://www.nature.com/articles/s41598-019-39060-1|journal=Scientific Reports|language=en|volume=9|issue=1|pages=|doi=10.1038/s41598-019-39060-1|issn=2045-2322|pmc=|pmid=30814539|access-date=|quote=|via=}}</ref> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6393470/ (Full text)]
*2019, [[Mitochondrial DNA|MtDNA]] population variation in Myalgic encephalomyelitis/Chronic fatigue syndrome in two populations: A study of mildly deleterious variants<ref>{{Cite journal | last = Venter | first = Marianne | author-link = | last2 = Tomas | first2 = Cara | author-link2 = Cara Tomas | last3 = Pienaar | first3 = Ilse S. | author-link3 = | last4 = Strassheim | first4 = Victoria | author-link4 = Victoria Strassheim | last5 = Erasmus | first5 = Elardus | author-link5 = | last6 = Ng | first6 = Wan-Fai | author-link6 = | last7 = Howell | first7 = Neil | last8 = Newton | first8 = Julia L. | author-link8 = Julia Newton | last9 = Van der Westhuizen | first9 = Francois H. | date = Dec 2019 | title = MtDNA population variation in Myalgic encephalomyelitis/Chronic fatigue syndrome in two populations: a study of mildly deleterious variants |url =http://www.nature.com/articles/s41598-019-39060-1 | journal = Scientific Reports|language=en | volume = 9 | issue = 1| pages=|doi=10.1038/s41598-019-39060-1|issn=2045-2322|pmc=|pmid=30814539|access-date=|quote=|via=}}</ref> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6393470/ (Full text)]
*2019, The role of mitochondria in ME/CFS: a perspective<ref>{{Cite journal|last=Tomas|first=Cara|author-link=Cara Tomas|last2=Elson|first2=Joanna L|author-link2=|author-link3=|author-link4=|author-link5=|date=2019-02-26|title=The role of mitochondria in ME/CFS: a perspective|url=https://www.tandfonline.com/doi/full/10.1080/21641846.2019.1580855|journal=Fatigue: Biomedicine, Health & Behavior|language=en|volume=|issue=|pages=1–7|doi=10.1080/21641846.2019.1580855|issn=2164-1846|quote=|via=}}</ref> - [https://www.tandfonline.com/doi/abs/10.1080/21641846.2019.1580855?journalCode=rftg20 (Abstract)]
*2019, The role of mitochondria in ME/CFS: a perspective<ref>{{Cite journal | last = Tomas | first = Cara | author-link = Cara Tomas | last2 = Elson | first2 = Joanna L | date = 2019-02-26 | title = The role of mitochondria in ME/CFS: a perspective | url =https://www.tandfonline.com/doi/full/10.1080/21641846.2019.1580855|journal = Fatigue: Biomedicine, Health & Behavior |language=en | volume = | issue = | pages = 1–7|doi=10.1080/21641846.2019.1580855|issn=2164-1846|quote=|via=}}</ref> - [https://www.tandfonline.com/doi/abs/10.1080/21641846.2019.1580855?journalCode=rftg20 (Abstract)]
*2019, [[mitochondrion|Mitochondrial]] complex activity in permeabilised cells of chronic fatigue syndrome patients using two cell types<ref>{{Cite journal|last=Tomas|first=Cara|author-link=Cara Tomas|last2=Brown|first2=Audrey E.|author-link2=Audrey Brown|last3=Newton|first3=Julia L.|author-link3=Julia Newton|last4=Elson|first4=Joanna L.|author-link4=|author-link5=|date=2019-03-01|title=Mitochondrial complex activity in permeabilised cells of chronic fatigue syndrome patients using two cell types|url=https://peerj.com/articles/6500|journal=PeerJ|language=en|volume=7|issue=|pages=e6500|doi=10.7717/peerj.6500|issn=2167-8359|pmc=|pmid=30847260|quote=|via=}}</ref> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398432/ (Full text)]
*2019, [[mitochondrion|Mitochondrial]] complex activity in permeabilised cells of chronic fatigue syndrome patients using two cell types<ref>{{Cite journal | last = Tomas | first = Cara | author-link = Cara Tomas | last2 = Brown | first2 = Audrey E. | author-link2 = Audrey Brown | last3 = Newton | first3 = Julia L. | author-link3 = Julia Newton | last4 = Elson | first4 = Joanna L. | author-link4 = | author-link5 = | date = 2019-03-01 | title = Mitochondrial complex activity in permeabilised cells of chronic fatigue syndrome patients using two cell types |url =https://peerj.com/articles/6500 | journal = PeerJ|language=en | volume = 7 | issue = | pages = e6500|doi=10.7717/peerj.6500|issn=2167-8359|pmc=|pmid=30847260|quote=|via=}}</ref> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398432/ (Full text)]
* 2019, Assessing cellular energy dysfunction in CFS/ME using a commercially available laboratory test<ref name="Morten2019">{{Cite journal|last=Morten|first=Karl J.|author-link=Karl Morten|last2=Newton|first2=Julia L.|author-link2=Julia Newton|first3=Joanna L.|last3=Elson|author-link3=Joanna Elson|last4=Potter|first4=Michelle|author-link4=Michelle Potter|last5=Lodge|first5=Tiffany A.|author-link5=Tiffany Lodge|last6=Tomas|first6=Cara|author-link6=Cara Tomas|date=2019-08-07|title=Assessing cellular energy dysfunction in CFS/ME using a commercially available laboratory test|url=https://www.nature.com/articles/s41598-019-47966-z|journal=Scientific Reports|language=en|volume=9|issue=1|pages=1–9|doi=10.1038/s41598-019-47966-z|issn=2045-2322|quote=|via=}}</ref> - [https://www.nature.com/articles/s41598-019-47966-z (Full text)]
* 2019, Assessing cellular energy dysfunction in CFS/ME using a commercially available laboratory test<ref name="Morten2019">{{Cite journal | last = Morten | first = Karl J. | author-link = Karl Morten | last2 = Newton | first2 = Julia L. | author-link2 = Julia Newton | first3 = Joanna L. | last3 = Elson | author-link3 = Joanna Elson | last4 = Potter | first4 = Michelle | author-link4 = Michelle Potter | last5 = Lodge | first5 = Tiffany A. | author-link5 = Tiffany Lodge | last6 = Tomas | first6 = Cara | author-link6 = Cara Tomas | date = 2019-08-07 | title = Assessing cellular energy dysfunction in CFS/ME using a commercially available laboratory test | url = https://www.nature.com/articles/s41598-019-47966-z | journal = Scientific Reports|language=en | volume = 9 | issue = 1 | pages = 1–9|doi=10.1038/s41598-019-47966-z|issn=2045-2322|quote=|via=}}</ref> - [https://www.nature.com/articles/s41598-019-47966-z (Full text)]
*2020, The effect of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) severity on cellular bioenergetic function<ref name="Tomas2020">{{Cite journal|last=Tomas|first=Cara|author-link=Cara Tomas|first2=Joanna L.|last2=Elson|author-link2=Joanna Elson|last3=Newton|first3=Julia L.|author-link3=Julia Newton|last4=Strassheim|first4=Victoria|author-link4=Victoria Strassheim|last5=Walker|first5=Mark|author-link5=Mark Walker|date=2020-04-10|title= The effect of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) severity on cellular bioenergetic function|url=https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0231136 |journal= PLoS ONE |language=en|volume=15|issue=4|pages=e0231136|doi=10.1371/journal.pone.0231136|issn=|quote=|via=}}</ref> - [https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0231136 (Full text)]
*2020, The effect of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) severity on cellular bioenergetic function<ref name="Tomas2020">{{Cite journal | last = Tomas | first = Cara | author-link = Cara Tomas | first2 = Joanna L. | last2 = Elson | author-link2 = Joanna Elson | last3 = Newton | first3 = Julia L. | author-link3 = Julia Newton | last4 = Strassheim | first4 = Victoria | author-link4 = Victoria Strassheim | last5 = Walker | first5 = Mark | author-link5 = Mark Walker | date = 2020-04-10 | title = The effect of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) severity on cellular bioenergetic function | url =https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0231136 | journal = PLoS ONE |language=en | volume = 15 | issue = 4| pages = e0231136|doi=10.1371/journal.pone.0231136|issn=|quote=|via=}}</ref> - [https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0231136 (Full text)]
*2020, Substrate utilisation of cultured skeletal muscle cells in patients with CFS<ref>{{Cite journal | last = Tomas | first = Cara | author-link = Cara Tomas | last2 = Elson | first2 = Joanna L. | author-link2 = | last3 = Newton | first3 = Julia L. | author-link3 = Julia Newton | last4 = Walker | first4 = Mark | author-link4 = | date = Dec 2020 | title = Substrate utilisation of cultured skeletal muscle cells in patients with CFS | url = http://www.nature.com/articles/s41598-020-75406-w | journal = Scientific Reports|language=en | volume = 10 | issue = 1 | pages = 18232|doi=10.1038/s41598-020-75406-w|issn=2045-2322|pmc =  7588462|pmid=33106563|access-date=|quote=|via=}}</ref> - [https://www.nature.com/articles/s41598-020-75406-w (Full text)]


==Talks and interviews==
==Talks and interviews==
* 4 May 2018 -Speaker at [[ME/CFS Canadian Collaborative Team Conference]] - ''Cellular Bioenergetics is Impaired in Patients with ME/CFS''<ref>{{Cite web|url=https://fourwaves-sots.s3.amazonaws.com/static/media/uploads/5FFGG5h0kBRlJTgexdugaQ%3D%3D/2018/04/24/me_cfs_final-program.pdf|title=ME/CFS Canadian Collaborative Team Conference|last=|first=|authorlink=|last2=|first2=|authorlink2=|date=|website=|archive-url=|archive-date=|dead-url=|access-date=2019-03-11}}</ref>
* 4 May 2018 -Speaker at [[ME/CFS Canadian Collaborative Team Conference]] - ''Cellular Bioenergetics is Impaired in Patients with ME/CFS''<ref>{{Cite web | url = https://fourwaves-sots.s3.amazonaws.com/static/media/uploads/5FFGG5h0kBRlJTgexdugaQ%3D%3D/2018/04/24/me_cfs_final-program.pdf | title=ME/CFS Canadian Collaborative Team Conference | last = | first = | author-link = | date = | website = | archive-url = | archive-date = |url-status = | access-date=2019-03-11}}</ref>
* 20 Sep 2018 - Speaker at [[CFS/ME Research Collaborative Conference|UK CFS/ME Research Collaborative Conference]]; Title - ''[https://www.youtube.com/watch?v=cqw0q38eDss Cellular bioenergetics in ME/CFS]''<ref>{{Cite web|url=https://www.actionforme.org.uk/uploads/images/2018/09/cmrc-2018-programme-final-revision.pdf|title=UK CFS/ME Research Collaborative Conference programme|last=|first=|authorlink=|last2=|first2=|authorlink2=|date=|website=Action for ME|archive-url=|archive-date=|dead-url=|access-date=2019-03-05}}</ref>
* 20 Sep 2018 - Speaker at [[CFS/ME Research Collaborative Conference|UK CFS/ME Research Collaborative Conference]]; Title - ''[https://www.youtube.com/watch?v=cqw0q38eDss Cellular bioenergetics in ME/CFS]''<ref>{{Cite web | url = https://www.actionforme.org.uk/uploads/images/2018/09/cmrc-2018-programme-final-revision.pdf | title=UK CFS/ME Research Collaborative Conference programme | last = | first = | author-link = | date = | website = Action for ME| archive-url = | archive-date = |url-status = | access-date=2019-03-05}}</ref>


==Online presence==
==Online presence==
Line 29: Line 30:
==References==
==References==
<references>
<references>
<ref name="Tomas, 2017">{{Citation
<ref name="Tomas, 2017">{{Citation | last1 = Tomas | first1 = Cara| author-link1 = Cara Tomas | last2 = Finkelmeyer | first2 = Andreas | author-link2 = Andreas Finkelmeyer | last3 = Hodgson | first3 = Tim| author-link3 = | last4 = MacLachlan | first4 = Laura | author-link4 = | last5 = MacGowan | first5 = Guy A | author-link5 = | last6 = Blamire | first6 = Andrew M | author-link6 = | last7 = Newton | first7 = Julia L | author-link8 = Julia Newton | title = Elevated brain natriuretic peptide levels in chronic fatigue syndrome associate with cardiac dysfunction: a case control study | journal =Open Heart | volume = | issue = | page = | date = 2017 | pmid = | doi = 10.1136/openhrt-2017-000697 | url = https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5761285/ }}</ref>
| last1   = Tomas             | first1 = Cara           | authorlink1 = Cara Tomas
<ref name="Tomas, 2018">{{Citation | last1 = Tomas | first1 = Cara| author-link1 = Cara Tomas | last2 = Newton | first2 = Julia L | author-link2 = Julia Newton | title = Metabolic abnormalities in chronic fatigue syndrome/myalgic encephalomyelitis: a mini-review | journal = Biochemical Society Transactions | volume = | issue = | page = | date = 2018 | pmid = 29666214 | doi = 10.1042/BST20170503 }}</ref>
| last2   = Finkelmeyer       | first2 = Andreas         | authorlink2 = Andreas Finkelmeyer
| last3   = Hodgson           | first3 = Tim             | authorlink3 =  
| last4   = MacLachlan       | first4 = Laura           | authorlink4 =  
| last5   = MacGowan         | first5 = Guy A           | authorlink5 =  
| last6   = Blamire           | first6 = Andrew M       | authorlink6 =  
| last7   = Newton           | first7 = Julia L         | authorlink7 = Julia Newton
| title   = Elevated brain natriuretic peptide levels in chronic fatigue syndrome associate with cardiac dysfunction: a case control study
| journal = Open Heart | volume =   | issue =   | page =  
| date   = 2017
| pmid   =  
| doi     = 10.1136/openhrt-2017-000697
| url     = https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5761285/
}}
</ref>
<ref name="Tomas, 2018">{{Citation
| last1   = Tomas             | first1 = Cara           | authorlink1 = Cara Tomas  
| last2   = Newton           | first2 = Julia L         | authorlink2 = Julia Newton
| title   = Metabolic abnormalities in chronic fatigue syndrome/myalgic encephalomyelitis: a mini-review
| journal = Biochemical Society Transactions | volume =   | issue =   | page =  
| date   = 2018
| pmid   = 29666214
| doi     = 10.1042/BST20170503  
}}
</ref>
</references>
</references>


Latest revision as of 22:39, May 18, 2023

Cara Tomas.png

Cara Tomas, PhD, is a Postdoctoral Research Associate at the Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK. Tomas' interest in ME/CFS stems from her own experience with acute onset ME/CFS leaving her bedbound for a time.[1]

Notable studies[edit | edit source]

Talks and interviews[edit | edit source]

Online presence[edit | edit source]

See also[edit | edit source]

Learn more[edit | edit source]

References[edit | edit source]

  1. ↑ 1.0 1.1 Streeten, David H.P.; Bell, David S. (January 1998). "Circulating Blood Volume in Chronic Fatigue Syndrome". Journal of Chronic Fatigue Syndrome. 4 (1): 3–11. doi:10.1300/j092v04n01_02. ISSN 1057-3321.
  2. ↑ Tomas, Cara; Brown, Audrey; Strassheim, Victoria; Elson, Joanna; Newton, Julia; Manning, Philip (October 24, 2017). "Cellular bioenergetics is impaired in patients with chronic fatigue syndrome". PLOS ONE. 12 (10): e0186802. doi:10.1371/journal.pone.0186802. ISSN 1932-6203. PMID 29065167.
  3. ↑ Tomas, Cara; Finkelmeyer, Andreas; Hodgson, Tim; MacLachlan, Laura; MacGowan, Guy A; Blamire, Andrew M; Newton, Julia L (2017), "Elevated brain natriuretic peptide levels in chronic fatigue syndrome associate with cardiac dysfunction: a case control study", Open Heart, doi:10.1136/openhrt-2017-000697
  4. ↑ Tomas, Cara; Newton, Julia L (2018), "Metabolic abnormalities in chronic fatigue syndrome/myalgic encephalomyelitis: a mini-review", Biochemical Society Transactions, doi:10.1042/BST20170503, PMID 29666214
  5. ↑ Xu, Jiabao; Potter, Michelle; Tomas, Cara; Elson, Jo; Morten, Karl; Poulton, Joanna; Wang, Ning; Jin, Hanqing; Hou, Zhaoxu (2018). "A new approach to find biomarkers in chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) by single-cell Raman micro-spectroscopy". The Analyst. doi:10.1039/C8AN01437J. ISSN 0003-2654.
  6. ↑ Venter, Marianne; Tomas, Cara; Pienaar, Ilse S.; Strassheim, Victoria; Erasmus, Elardus; Ng, Wan-Fai; Howell, Neil; Newton, Julia L.; Van der Westhuizen, Francois H. (December 2019). "MtDNA population variation in Myalgic encephalomyelitis/Chronic fatigue syndrome in two populations: a study of mildly deleterious variants". Scientific Reports. 9 (1). doi:10.1038/s41598-019-39060-1. ISSN 2045-2322. PMID 30814539.
  7. ↑ Tomas, Cara; Elson, Joanna L (February 26, 2019). "The role of mitochondria in ME/CFS: a perspective". Fatigue: Biomedicine, Health & Behavior: 1–7. doi:10.1080/21641846.2019.1580855. ISSN 2164-1846.
  8. ↑ Tomas, Cara; Brown, Audrey E.; Newton, Julia L.; Elson, Joanna L. (March 1, 2019). "Mitochondrial complex activity in permeabilised cells of chronic fatigue syndrome patients using two cell types". PeerJ. 7: e6500. doi:10.7717/peerj.6500. ISSN 2167-8359. PMID 30847260.
  9. ↑ Morten, Karl J.; Newton, Julia L.; Elson, Joanna L.; Potter, Michelle; Lodge, Tiffany A.; Tomas, Cara (August 7, 2019). "Assessing cellular energy dysfunction in CFS/ME using a commercially available laboratory test". Scientific Reports. 9 (1): 1–9. doi:10.1038/s41598-019-47966-z. ISSN 2045-2322.
  10. ↑ Tomas, Cara; Elson, Joanna L.; Newton, Julia L.; Strassheim, Victoria; Walker, Mark (April 10, 2020). "The effect of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) severity on cellular bioenergetic function". PLoS ONE. 15 (4): e0231136. doi:10.1371/journal.pone.0231136.
  11. ↑ Tomas, Cara; Elson, Joanna L.; Newton, Julia L.; Walker, Mark (December 2020). "Substrate utilisation of cultured skeletal muscle cells in patients with CFS". Scientific Reports. 10 (1): 18232. doi:10.1038/s41598-020-75406-w. ISSN 2045-2322. PMC 7588462. PMID 33106563.
  12. ↑ "ME/CFS Canadian Collaborative Team Conference" (PDF). Retrieved March 11, 2019.
  13. ↑ "UK CFS/ME Research Collaborative Conference programme" (PDF). Action for ME. Retrieved March 5, 2019.

myalgic encephalomyelitis (M.E.) - A disease often marked by neurological symptoms, but fatigue is sometimes a symptom as well. Some diagnostic criteria distinguish it from chronic fatigue syndrome, while other diagnostic criteria consider it to be a synonym for chronic fatigue syndrome. A defining characteristic of ME is post-exertional malaise (PEM), or post-exertional neuroimmune exhaustion (PENE), which is a notable exacerbation of symptoms brought on by small exertions. PEM can last for days or weeks. Symptoms can include cognitive impairments, muscle pain (myalgia), trouble remaining upright (orthostatic intolerance), sleep abnormalities, and gastro-intestinal impairments, among others. An estimated 25% of those suffering from ME are housebound or bedbound. The World Health Organization (WHO) classifies ME as a neurological disease.

Retrieved from "https://me-pedia.org/w/index.php?title=Cara_Tomas&oldid=240787"